Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Elena Klonoski

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

klonoski_elena_blog_150x150.png

klonoski_eleana_common_640x280.jpg

klonoski_elena_heroretina_2700x1160.jpg

klonoski_eleana_mobileretina_750x1040.jpg

klonoski_elena_social_600x600.jpg

Elena Klonoski is an associate in Morrison Foerster’s Boston office and a member of the firm’s FDA + Healthcare Regulatory and...

Elena Catherine Klonoski

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

Case Studies

MoFo Presents: The “Top 5” Summer Series at CIC  Essential Insights for Entrepreneurs & Innovators

Events

Experience

AI Transparency in Healthcare: Navigating a Changing Regulatory Landscape

FDA Draft Guidance on Artificial Intelligence-Enabled Device Software Functions

DOJ Announces $2.92 Billion in False Claims Act Recoveries in Fiscal Year 2024

FDA Releases Draft Guidance on Evaluating the Risk and Credibility of AI Used in Establishing Drug and Device Safety, Effectiveness, and Quality

Medicare Drug Price Negotiation Program Final Guidance

The EU’s New Proposal for Plants Developed Using New Genomic Techniques: How Does it Compare to U.S. Regulation?

Insights

News

Podcasts

Boston

FDA + Healthcare Regulatory and Compliance

eklonoski@mofo.com

(617) 648-4641

Video + Audio